Autism spectrum disorder (ASD) is marked by social disability and is associated with dysfunction in brain circuits supporting social-cue perception. The degree to which neural functioning reflects individual-level behavioural phenotype … Continue Reading Neuroimaging study identifies new biomarker for autism spectrum disorder in boys.
With Parkinson’s disease clinicians have long noted that the presence of tremors, rather than balance and walking problems is the initial or dominant symptom and hypothesize this may even suggest … Continue Reading Human study identifies genetic variation for type and rate of physical decline Parkinson’s disease.
A major problem of Alzheimer’s disease diagnosis is by the time the first clinical symptoms appear, massive irreversible damage to the brain has already occurred. At that point, symptomatic treatment … Continue Reading New infrared sensor extracts amlyloid-beta from blood for early detection of Alzheimer’s.
Being able to detect early on whether a cancer therapy is working proffers obvious benefits for therapy-outcomes whilst influencing the course of treatment and improving the quality of life for … Continue Reading Novel ‘reporter’ nanoparticle reveals cancer treatment effectiveness in real-time.
Pancreatic cancer is a devastating disease, with a death rate close to the incidence rate. Because more than 90% of pancreatic cancer cases are diagnosed at the metastatic stage, when … Continue Reading Early indicators of pancreatic cancer identified in precision medicine study.
Ebola virus disease (EVD) is a severe infectious disease which caused an epidemic in West Africa in 2013-2015, and has resulted in at least 10,000 confirmed deaths. Early diagnosis of … Continue Reading Cell-free microRNA identified as biomarker for early diagnosis of Ebola.
It is known that the age-related growth differentiation factor 11 (GDF11) is member of the transforming growth factor β superfamily of proteins. Circulating GDF11 concentrations appear to decline with age, … Continue Reading Study identifies previously unknown molecular pathway in aging.
As the population continues to age, the need for biological measures of age and more precise screening tests for age-related diseases is becoming increasingly urgent. Epigenetics serves as an intersection … Continue Reading New epigenetic predictor of cancer validated in human study.
It is known that chronic inflammation in the gut increases the risk of colon cancer by as much as 500%. Therefore, the genetic basis and mechanism of cancer proliferation in … Continue Reading Researchers show how gut inflammation initiates colon cancer.
With Alzheimer’s disease medical professionals have to conduct costly brain imaging scans, and sometimes, invasive cerebral spinal fluid tests to rule out other diseases. Now, a new study from researchers … Continue Reading Human study identifies biomarker in blood for Alzheimer’s disease.
Type 2 diabetes is a chronic illness characterised by the presence of elevated blood glucose levels. It accounts for between 80 and 90% of diabetes cases and is one of … Continue Reading Large-scale study identifies an epigenetic marker for Type 2 diabetes.
Preeclampsia, which affects 5 to 8% of pregnancies worldwide, is characterized by high blood pressure and protein in the urine. The disorder is the number one reason physicians decide to … Continue Reading New field-based test for preeclampsia validated in large-scale study.
Pre-term birth is a birth which takes place before 37 weeks of pregnancy. According to the Centers for Disease Control and Prevention, in 2014, preterm birth affected one out of … Continue Reading Large-scale study successfully validates test for preterm birth risk.
Major depressive disorder is a highly familial illness and the leading cause of disability worldwide for persons 15 to 44 years of age. It is associated with increased mortality resulting … Continue Reading Study shows that both genetics and environment impact depression.
Melanoma incidence has been rapidly increasing worldwide, with fewer than 10% of people whose melanoma tumours have spread or metastasized surviving longer than a decade after detection. Despite the considerable … Continue Reading New ctDNA blood-test for melanoma beats standardised test in human trials.
Alzheimer’s disease is a progressive illness that is the leading cause of dementia and the sixth leading cause of death in the United States. There is no cure for the … Continue Reading Neuroimaging links two Alzheimer’s risk genes to brain atrophy, promising blood markers.